Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04702451 · ClinicalTrials.gov registry record · NA
Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation
A NA study, sponsored by Volta Medical.
- Completed
- Registry status
- NA
- Development phase
- 377
- Enrollment target
NCT04702451 is a NA study that has completed, run by Volta Medical. The registered enrollment target is 377 participants.
The verdict
NCT04702451, a NA study, has completed, sponsored by Volta Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 377 participants
- Enrollment target
Study Summary
Atrial Fibrillation (AF) ablation is typically performed in predefined anatomic regions of the left atrium without attempting to identify patient-specific areas of interest. This procedure is referred to as Pulmonary Vein Isolation (PVI). The hypothesis in this Study is that a tailored ablation strategy targeting areas of spatio-temporal dispersion in combination with PVI is superior to an anatomical ablation strategy targeting PVI alone for the treatment of persistent AF.
Interventions
- PROCEDURE Dispersion ablation + PVI
- DEVICE VX1
- PROCEDURE PVI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 377 participants |
| Start Date | 2021-02-12 |
| Est. Completion | 2023-12-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04702451
The ClinicalTrials.gov registry entry for NCT04702451 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 377 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Volta Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dispersion ablation + PVI is the first listed.
NCT04702451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04702451 about?
NCT04702451 is a clinical study titled "Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation". Atrial Fibrillation (AF) ablation is typically performed in predefined anatomic regions of the left atrium without attempting to identify patient-specific areas of interest. This procedure is referred to as Pulmonary Vein Isolation (PVI). The hypothesis in this Study is that a tailored ablation str...
What is the current status of trial NCT04702451?
This trial is currently completed. It is a NA study. The enrollment target is 377 participants. The study started on 2021-02-12. Estimated completion is 2023-12-27.
What interventions are being tested in trial NCT04702451?
The interventions under investigation include: Dispersion ablation + PVI (PROCEDURE), VX1 (DEVICE), PVI (PROCEDURE).
Who is sponsoring clinical trial NCT04702451?
This trial is sponsored by Volta Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.